Watson CFO Mark W. Durand to Take Leave of Absence
July 27 2009 - 4:40PM
PR Newswire (US)
MORRISTOWN, N.J., July 27 /PRNewswire-FirstCall/ -- Watson
Pharmaceuticals, Inc. (NYSE:WPI), a leader in generic and specialty
branded pharmaceuticals, announced that effective today Mark W.
Durand, Senior Vice President and Chief Financial Officer, has
taken a leave of absence from the Company for health reasons. Paul
Bisaro, President and Chief Executive Officer of Watson, announced
that R. Todd Joyce, Vice President, Corporate Controller and
Treasurer, will serve as Acting Principal Financial Officer,
effective immediately. About Watson Pharmaceuticals, Inc. Watson
Pharmaceuticals, Inc., (NYSE:WPI) is a global leader in the
development and distribution of pharmaceuticals with a broad
portfolio of generic products and a specialized portfolio of
branded pharmaceuticals focused on Urology, Gynecology and
Nephrology (Medical). For press releases and other company
information, visit the Watson website at http://www.watson.com/.
Forward-Looking Statement Any statements contained in this press
release that refer to future events or other non-historical facts
are forward-looking statements that reflect Watson's current
perspective of existing trends and information as of the date of
this release. Except as expressly required by law, Watson disclaims
any intent or obligation to update these forward-looking
statements. Actual results may differ materially from Watson's
current expectations depending upon a number of factors affecting
Watson's business. These factors include, among others, the risks
and uncertainties detailed in Watson's periodic public filings with
the Securities and Exchange Commission, including but not limited
to Watson's Annual Report on Form 10-K for the year ended December
31, 2008. (Logo:
http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO)
http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO
http://photoarchive.ap.org/ DATASOURCE: Watson Pharmaceuticals,
Inc. CONTACT: Patty Eisenhaur of Watson Pharmaceuticals, Inc.,
+1-951-493-5611 Web Site: http://www.watson.com/
Copyright